Cardiovascular Ultrasound System Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 1.44 Billion |
| Market Size (2029) | USD 1.89 Billion |
| CAGR (2024 - 2029) | 5.41 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cardiovascular Ultrasound System Market Analysis
The Global Cardiovascular Ultrasound System Market size is estimated at USD 1.44 billion in 2024, and is expected to reach USD 1.89 billion by 2029, growing at a CAGR of 5.41% during the forecast period (2024-2029).
COVID-19 had an unimaginable impact on the world and altered almost every aspect of the healthcare industry. The pandemic also had a complex and unprecedented effect on the ultrasound market. Healthcare providers deployed the potential of ultrasound diagnosis, primarily for point-of-care (POC) applications, for the triage, monitoring, and diagnosis of COVID-19 patients. As per the study published in March 2021, titled 'Application of Point-of-care Cardiac Ultrasonography in COVID-19 Infection: Lessons Learned from the Early Experience', since there is a high prevalence of acute cardiac injury in patients with COVID-19 infection, point-of-care cardiac ultrasound (PoCCUS) may be used for longitudinal monitoring of patients infected with COVID-19. Such studies demonstrating the application of cardiovascular ultrasound systems in COVID-19 patients are expected to positively support the growth of the market.
The major factors supporting the growth of the cardiovascular ultrasound system market include the increasing incidence of cardiovascular diseases (CVDs), technological advancements, and the advantages of echocardiography over invasive cardiac diagnostic procedures.
According to the June 2021 update of the World Health Organization (WHO), cardiovascular diseases are the leading cause of death around the world, and about three-quarters of deaths from CVDs are recorded in low- and middle-income countries and thus, due to the high mortality due to the CVDs, the demand for disease diagnostics and monitoring is increasing which is expected to fuel growth in the cardiovascular ultrasound system market. Further, according to the 2022 American Heart Association (AHA) report, approximately 244.1 million people were living with ischemic heart disease (IHD) around the world, and North Africa and the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of IHD in the world in 2020. This burden of cardiovascular diseases is further expected to increase due to the high prevalence of associated risk factors such as hypertension, obesity, smoking, diabetes, and others, along with the sedentary lifestyle; thus, the use of ultrasound in disease diagnostics, monitoring, and treatment is expected to increase which will drive growth in the cardiovascular ultrasound system market over the forecast period.
Technological advancements such as artificial intelligence have a significant positive impact on cardiology with improved ability to diagnose certain heart conditions. For instance, in October 2020, GE Healthcare received the United States Food and Drug Administration clearance for its ultra edition package of vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.
However, unfavorable reimbursement scenarios and the economic impact of adopting new technologies are likely to impede the studied market growth over the forecast period.
Cardiovascular Ultrasound System Market Trends
This section covers the major market trends shaping the Cardiovascular Ultrasound System Market according to our research experts:
The 2D Ultrasound Imaging Segment is Expected to be Fastest Growing Segment Over the Forecast Period
2D ultrasound imaging is also known as B-mode echography or sonography. It displays a 2D map of B-mode data and is currently the most common form of cardiac ultrasound imaging used worldwide. It uses multiple transducers. It enables the generation of multiple images of the field or frames every second on the screen, giving an illusion of movement. It is primarily used to measure cardiac chamber dimensions, assess valvular structure and function, and improve the accuracy of interpretation of Doppler modalities. 2D ultrasound is one of the most common forms of technology used.
Owing to the high prevalence of cardiovascular diseases and wide acceptance and usage of 2D ultrasound systems, the segment is expected to grow significantly over the forecast period. For instance, according to the 2022 report of the American Heart Association (AHA), there were about 68.2 million ischemic stroke cases, 18.9 million intracerebral hemorrhages, and 8.1 million cases of subarachnoid hemorrhages in 2020 which has increased from the previous year and thus, owing to the high burden of the CVDs, the segment is expected to grow over the forecast period.
Moreover, in October 2020, Royal Philips launched the Ultrasound 3300, a new innovative ultrasound series tailored for general Imaging and cardiovascular imaging procedures. Such product advancement will boost vertical growth over the coming years.
Thus, the segment is anticipated to witness significant growth over the forecast period due to the abovementioned factors.
North America is Expected to Dominate the Market Over the Forecast Period
North America is anticipated to lead the market owing to the high adoption of ultrasound modality in general diagnostics and the rising prevalence of lifestyle-associated chronic diseases. The high demand for technologically advanced medical devices is expected to propel market growth in the region.
The major factor driving the market is the rising global burden of various coronary heart diseases, such as stroke and cardiomyopathy, which cause a global burden of cardiac-related deaths. As per a report by the United States Centers for Disease Control (CDC), statistics updated in 2021, every 40 seconds, an American may have a heart attack. This scenario leads to a higher demand for cardiovascular ultrasound systems for better diagnosis, which will drive the market in the United States.
Moreover, in October 2020, GE Healthcare received the United States Food and Drug Administration's 510k clearance for its ultra-edition package of vivid cardiovascular ultrasound systems, which include new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Also, in September 2020, Philips Healthcare introduced the latest addition of dedicated cardiovascular ultrasound solutions, the Affiniti CVx, to support the cardiology departments in delivering better care to more patients with increased efficiency and throughput.
Furthermore, supportive awareness initiatives for disease awareness are projected to support the market for cardiovascular devices in North America. For instance, in February 2020, Mexico joined the HEARTS initiative to strengthen primary healthcare for CVD. Promoted by the Pan American Health Organization/ World Health Organization (PAHO/WHO), the initiative aims to improve the prevention and control of hypertension at the primary care level.
Thus, owing to the abovementioned factors, the North American region is expected to show lucrative growth over the forecast period.
Cardiovascular Ultrasound System Industry Overview
The market studied is moderately consolidated, owing to the presence of many small and large market players. Some market players are Canon Medical Systems, Chison, Esaote SpA, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips NV, Health Catalyst (KPI Healthcare Inc.), Samsung Healthcare, Siemens Healthcare, and Whale Imaging. Regional and service portfolio expansions and mergers and acquisitions are key strategic undertakings adopted by these players.
Cardiovascular Ultrasound System Market Leaders
-
Canon Medical Systems Corporation
-
Esaote SpA
-
GE Healthcare
-
Koninklijke Philips NV
-
Siemens Healthcare GmbH
*Disclaimer: Major Players sorted in no particular order
Cardiovascular Ultrasound System Market News
- In May 2022, Phillips launched EchoNavigator 4.0, the new release of its image-guided therapy solution for the treatment of structural heart disease.
- In May 2022, FUJIFILM VisualSonics launched the new multi-modal Vevo F2 imaging platform for a preclinical ultrasound.
Cardiovascular Ultrasound System Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Incidence of Cardiovascular Diseases (CVDs)
- 4.2.2 Rise in Technological Advancements
- 4.2.3 Advantages of Echocardiography over Invasive Cardiac Diagnostic Procedures
-
4.3 Market Restraints
- 4.3.1 Unfavorable Reimbursement Scenario
- 4.3.2 Economic Impact of Adopting New Technologies
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Test Type
- 5.1.1 Transthoracic Echocardiogram
- 5.1.2 Transesophageal Echocardiogram
- 5.1.3 Stress Echocardiogram
- 5.1.4 Other Test Types
-
5.2 By Technology
- 5.2.1 2D
- 5.2.2 3D and 4D
- 5.2.3 Doppler Imaging
-
5.3 By Device Display
- 5.3.1 Color Display
- 5.3.2 Black and White (B/W) Display
-
5.4 By End User
- 5.4.1 Hospitals
- 5.4.2 Ambulatory Centers
- 5.4.3 Other End Users
-
5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Middle-East and Africa
- 5.5.4.1 GCC
- 5.5.4.2 South Africa
- 5.5.4.3 Rest of Middle-East and Africa
- 5.5.5 South America
- 5.5.5.1 Brazil
- 5.5.5.2 Argentina
- 5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Canon Medical Systems
- 6.1.2 Chison
- 6.1.3 Clarius Mobile Health
- 6.1.4 Esaote SpA
- 6.1.5 GE Healthcare
- 6.1.6 FUJIFILM Holdings Corporation
- 6.1.7 Koninklijke Philips NV
- 6.1.8 Medisono LLC
- 6.1.9 Samsung Healthcare
- 6.1.10 Siemens Healthcare GmbH
- 6.1.11 Whale Imaging
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityCardiovascular Ultrasound System Industry Segmentation
As per the scope of this report, cardiovascular ultrasound systems use the ultrasound imaging technique to provide images of the heart. The cardiovascular ultrasound system market is segmented by test type (transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other test types), technology (2D, 3D, and 4D, and Doppler imaging), device display (color display and black and white (b/w) display), end user (hospitals, ambulatory centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.
| By Test Type | Transthoracic Echocardiogram | |
| Transesophageal Echocardiogram | ||
| Stress Echocardiogram | ||
| Other Test Types | ||
| By Technology | 2D | |
| 3D and 4D | ||
| Doppler Imaging | ||
| By Device Display | Color Display | |
| Black and White (B/W) Display | ||
| By End User | Hospitals | |
| Ambulatory Centers | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Cardiovascular Ultrasound System Market Research FAQs
How big is the Global Cardiovascular Ultrasound System Market?
The Global Cardiovascular Ultrasound System Market size is expected to reach USD 1.44 billion in 2024 and grow at a CAGR of 5.41% to reach USD 1.89 billion by 2029.
What is the current Global Cardiovascular Ultrasound System Market size?
In 2024, the Global Cardiovascular Ultrasound System Market size is expected to reach USD 1.44 billion.
Who are the key players in Global Cardiovascular Ultrasound System Market?
Canon Medical Systems Corporation, Esaote SpA, GE Healthcare, Koninklijke Philips NV and Siemens Healthcare GmbH are the major companies operating in the Global Cardiovascular Ultrasound System Market.
Which is the fastest growing region in Global Cardiovascular Ultrasound System Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Cardiovascular Ultrasound System Market?
In 2024, the North America accounts for the largest market share in Global Cardiovascular Ultrasound System Market.
What years does this Global Cardiovascular Ultrasound System Market cover, and what was the market size in 2023?
In 2023, the Global Cardiovascular Ultrasound System Market size was estimated at USD 1.37 billion. The report covers the Global Cardiovascular Ultrasound System Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Cardiovascular Ultrasound System Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Cardiovascular Ultrasound Industry Report
Statistics for the 2024 Cardiovascular Ultrasound market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cardiovascular Ultrasound analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
